N-乙基 -甲基-全氟酸 3-[(1S)-1-(二甲基氨基)乙基] 苯酯酒石酸酯

产品名称：

129101-54-8
Rivastigmine tartrate
ENA-713
S-Rivastigmine tartrate
N-Ethyl-N-methyl-carbamic acid 3-[(1S)-1-(dimethylamino)ethyl]phenyl ester tartrate
Ethylmethyl-carbamic acid 3-[(1S)-1-(dimethylamino)ethyl]phenyl ester
卡巴拉汀酒石酸酯
N-乙基 -甲基-全氟酸 3-[(1S)-1-(二甲基氨基)乙基] 苯酯酒石酸酯
酒石酸卡巴拉汀酒石酸酯
乙基甲基氨基甲酸 3-[(1S)-1-(二甲基氨基)乙基]苯基酯

产品介绍：

产品说明

一般描述

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.
For further information and support please go to the website of the issuing Pharmacopoeia.

生化/生理作用

卡巴拉汀是一种口服口服、脑透过性、可逆的胆碱酯酶抑制剂，可增强阿尔茨海默症和帕金森氏病患者的认知功能。卡巴拉汀可同时抑制丁酰胆碱酯酶和乙酰胆碱酯酶。

分析说明

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.

其他说明

USP issued SDS can be found here.
Sales restrictions may apply.

基本信息

经验(实验)分子式	C₁₄H₂₂N₂O₂· C₄H₆O₆
分子量	400.42
NACRES	NA.24

产品性质

等级	pharmaceutical primary standard
manufacturer/tradename	USP
application(s)	pharmaceutical (small molecule)
格式	neat
储存温度	2-8℃
InChI	1S/C14H22N2O2.C4H6O6/c1-6-16(5)14(17)18-13-9-7-8-12(10-13)11(2)15(3)4;5-1(3(7)8)2(6)4(9)10/h7-11H,6H2,1-5H3;1-2,5-6H,(H,7,8)(H,9,10)/t11-;1-,2-/m00/s1
InChI key	GWHQHAUAXRMMOT-RWALOXMOSA-N

安全信息

象形图
警示用语：	Danger
危险声明	H300 - H411
预防措施声明	P264 - P270 - P273 - P301 + P310 - P391 - P405
危险分类	Acute Tox. 2 Oral - Aquatic Chronic 2
储存分类代码	6.1A - Combustible, acute toxic Cat. 1 and 2 / very toxic hazardous materials
WGK	WGK 3
闪点(F)	Not applicable
闪点(C)	Not applicable

Rivastigmine tartrate

卡巴拉汀 酒石酸酯

卡巴拉汀酒石酸酯